Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The *quorum-sensing circuit in engineered Escherichia coli Nissle 1917* refers to a synthetic or natural regulatory system enabling these bacterial cells to detect specific diffusible chemical signals (autoinducers, such as AI-2), and coordinately alter gene expression in response to changes in population density or the presence of other microbial or host signals. In Nissle 1917, the primary relevant native circuit is the AI-2 quorum-sensing pathway, which uses the LuxS enzyme to produce AI-2 for interspecies communication and regulation of behaviors including colonization and immune modulation. Engineered circuits typically introduce synthetic promoters and response elements, enabling new therapeutic or antimicrobial activities in response to quorum-sensing signals, particularly for programmable probiotic interventions. This is not a canonical molecular target but an engineered regulatory system used in the context of synthetic biology and microbiome therapeutics.
Regulation of bacterial gene expression by sensing extracellular concentrations of autoinducers (such as AI-2 synthesized via LuxS pathway in Nissle 1917) Activation or repression of downstream synthetic genes, e.g., for therapeutic or antibacterial production in engineered strains Signal integration for population-density dependent behaviors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Quorum-sensing circuit in engineered Escherichia coli Nissle 1917 (null).